000 01386 a2200433 4500
005 20250513022443.0
264 0 _c19800627
008 198006s 0 0 eng d
022 _a0021-9150
024 7 _a10.1016/0021-9150(80)90025-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKashyap, M L
245 0 0 _aApolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.
_h[electronic resource]
260 _bAtherosclerosis
_cJan 1980
300 _a29-40 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aApolipoprotein C-II
650 0 4 _aApolipoproteins
_xmetabolism
650 0 4 _aApolipoproteins C
650 0 4 _aFemale
650 0 4 _aHeparin
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLipoprotein Lipase
_xmetabolism
650 0 4 _aLipoproteins, VLDL
_xmetabolism
650 0 4 _aLiver
_xenzymology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNephrotic Syndrome
_xenzymology
650 0 4 _aTriglycerides
_xmetabolism
700 1 _aSrivastava, L S
700 1 _aHynd, B A
700 1 _aBrady, D
700 1 _aPerisutti, G
700 1 _aGlueck, C J
700 1 _aGartside, P S
773 0 _tAtherosclerosis
_gvol. 35
_gno. 1
_gp. 29-40
856 4 0 _uhttps://doi.org/10.1016/0021-9150(80)90025-8
_zAvailable from publisher's website
999 _c7369595
_d7369595